Protara Therapeutics Inc (NAS:TARA)
$ 3.925 -0.11 (-2.73%) Market Cap: 220.60 Mil Enterprise Value: 87.87 Mil PE Ratio: 0 PB Ratio: 1.19 GF Score: 32/100

Protara Therapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 11:45 PM GMT
Release Date Price: $4.94 (+0.41%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TARA.OQ - Protara Therapeutics Inc
Protara Therapeutics Inc at JPMorgan Healthcare Conference
Jan 14, 2026 / 11:45PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome everyone. My name is Tayo Pabme and I'm welcoming you to the 4-fourth JP Morgan Healthcare Conference. Our next presenting company is Ptera Therapeutics. Pera is a clinical stage biotechnology company that's developing re transformative therapies for people with rare and cancer diseases.

And presenting today is CEO Jesse Shaefferman. Please help me welcome to the stage.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you.

Thanks Tyi.

Thank you to the JPMorgan team for having us. I'm looking forward to talking through
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot